Smoking Cessation in Substance Abuse Treatment Patients: A Feasibility Study

UConn Health

Status and phase

Completed

Phase 3

Conditions

Nicotine Dependence

Treatments

Behavioral: Contingency Management

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT00408265

NIH Grant P50-AA03510

NIAAA-ALE-03510

Details and patient eligibility

About

The purpose of this study is to compare the effects of self-help materials for smoking cessation and self-help materials for smoking cessation plus prize-based contingency management (CM), in which prize incentives are available for breath and saliva samples that indicate smoking abstinence, in substance abuse treatment patients who want to quit smoking.

Full description

The specific aims of this study are: (1) to examine the efficacy of self-help materials compared to self-help materials plus prize contingency management (CM) for smoking abstinence in substance abuse treatment patients and (2) examine the effects of smoking abstinence on substance use and substance treatment retention. To address these specific aims, cigarette smokers entering treatment for alcohol, cocaine or heroin abuse or dependence, who report daily smoking (at least one cigarette per day) for the past year, and who meet other inclusion and exclusion criteria, are randomly assigned to receive self-help materials or self-help materials plus CM. Individuals in the CM group have the opportunity to win prizes, worth on average $1, $20, or $100, when they meet smoking abstinence criteria (CO < 8ppm and salivary cotinine < 10ng/mL). Participants meet with research staff 4 times/week during Weeks 1-4, 2 times/week during Weeks 5-8 and 1 time/week during Weeks 9-12. Follow-up interviews are scheduled 1, 3 and 6 months following the smoking quit date.

Enrollment

80 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

meets diagnostic criteria for alcohol, cocaine or heroin abuse or dependence
self-report daily smoking for at least the past year
CO > 8ppm
interested in quitting smoking while in treatment,
minimum age 18 years old
willing to provide names, addresses and phone numbers of individuals to assist in locating the patient for follow-up evaluations
English speaking

Exclusion criteria

current use of NRT
current use of bupropion
serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, suicide risk)
dementia (Mini-mental status score of <23)
currently participating in another CM study at the clinic
in recovery for pathological gambling